For over four decades, Biolab has supported clients across the pharmaceutical, medical device and cosmetic industries with specialized analytical testing services that help bring safe and high-quality products to market. An independent laboratory with expertise in microbiology, toxicology, validation and biocompatibility testing, it gives clients access to an integrated framework built for full regulatory compliance. By identifying risks early, optimizing formulations and aligning workflows with ISO, USP and OECD standards, Biolab helps clients minimize disruption across their value chain and accelerate progress to market. Each stage includes clear documentation and interpretative reports that strengthen decision-making. Its defining strength lies in the combination of decades of experience and a bespoke service model. Unlike larger, one-size-fits-all providers, it adapts each method and workflow to the specific requirements of every client and product. The microbiology and toxicology services exemplify this approach, balancing scientific precision with flexibility and responsiveness. Operating without the constraints of a large parent organization allows the team to deliver tailored solutions without red tape. “Client focus is the cornerstone of our culture,” says Jaime Escario, CEO. “We treat each client equally, independently of their figures.” With extensive experience supporting more than 100 clients worldwide, Biolab understands the pressures of handling regulatory requirements while maintaining development timelines. Accurate, on-time completion of all quality control and safety tests remains a core priority, helping clients avoid delays and prevent noncompliance. Turning analytical data into meaningful insight adds to the complexity, which requires scientific depth and interpretative clarity. Biolab addresses this through end-to-end support covering method development, validation, execution, reporting and interpretation. Clients gain direct access to experienced technicians and QA specialists who identify potential issues at early stages and resolve them with precision. An agile workflow and open communication channels allow Biolab to adjust to evolving project needs without any compromise on quality or compliance..

Modern drug and vaccine development hinges on one essential truth that life-changing therapies are born from scientific data that must be trusted across continents. As trials become increasingly global and assays more complex, sponsors struggle to maintain data quality, regulatory compliance and operational harmony across multiple laboratories. Success depends on not just great science, but the ability to ensure precision and speed at scale. Cerba Research empowers clinical trial sponsors, pharma and biotech companies and contract research organizations to translate their vision into life-changing therapies for patients worldwide. State-of-the-art specialty and central laboratory solutions are at the heart of its offerings. The solutions help clients run the world’s most complex clinical trials with accuracy, scale and scientific intelligence. Cerba Research drives breakthroughs across high-impact therapeutic areas, from virology and vaccines, oncology and immunology to infectious diseases and gene therapy. With the integration of Viroclinics-DDL, its laboratories specialize in infectious disease research, offering advanced virological, immunological and molecular assays under one roof. They are equipped with a wide range of testing, from routine safety to advanced molecular and genetic assays. A robust portfolio of specialty laboratory solutions supports the full drug and vaccine development lifecycle, helping clients from the preclinical to post-marketing and approval phases. The deep expertise and agility of a specialist laboratory combine with the capacity, breadth, and global reach of a central lab. “Our goal is to support complex clinical trials through deep scientific knowledge and scalable infrastructure,” says Maria Fotiu, CEO and managing director. With laboratories across five continents, clients can tap into services that include protocol review, kit design and sample handling. Additional services include biobanking, testing and reporting, all delivered through a unified global database. Cerba Research maintains BSL-3 certification across multiple sites. This ensures global access to high-containment facilities that support customers wherever their studies are conducted. All laboratory services are backed by standardized, harmonized workflows. Validation is a defining force, enabling Cerba Research to establish and drive rigorous standards across both internal and partner labs. The same capabilities and quality are delivered across regions, providing a unified experience that reduces protocol deviations and accelerates trial timelines. .

Cormica has strengthened the safety and performance of medical devices, pharmaceuticals and combination products for more than sixty years through precise testing and regulatory expertise. Built on scientific rigour and a focus on patient outcomes, the company delivers analytical chemistry, microbiology and physical testing services that help manufacturers release products safely and on time across global markets. Its microbiology division provides sterility, bioburden, endotoxin and microbial identification testing that complies with USP and Ph. Eur. standards. These capabilities ensure the microbiological integrity of every stage of product development. “The two biggest things that we value are quality and patient safety. That for us comes above all else we do,” says Dr. Rob Turner, General Manager of Wickham Micro. A One-Stop Global Testing Partner Cormica’s network of accredited laboratories operates under the oversight of the MHRA, FDA and UKAS. Client audits occur every week of the year, ensuring processes remain fully compliant and transparent. This constant scrutiny has built a reputation for reliability. With laboratories in the UK, the United States and Europe, Cormica offers clients a single testing ecosystem that covers analytical, physical and microbiological disciplines maintaining turnaround speed and consistency. The recent acquisition of Zwisler Laboratorium GmbH in Germany expanded European coverage and improved cross-border capacity balancing. Guiding Clients through Regulatory Complexity Working across multiple regions means managing different documentation and validation requirements, including the added post-Brexit complexity of separate regulatory frameworks. Cormica helps clients navigate these challenges through collaborative validation planning and compliance mapping. The goal is to prevent costly remediation and ensure timely market release. Cormica’s teams stay ahead of changing expectations, most notably, by attending regulatory conferences and contributing to discussions that shape industry standards..